<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04357925</url>
  </required_header>
  <id_info>
    <org_study_id>19_RIPH3_08</org_study_id>
    <secondary_id>2019-A02116-51</secondary_id>
    <nct_id>NCT04357925</nct_id>
  </id_info>
  <brief_title>Quality of Life in Prostate Cancer Patients</brief_title>
  <acronym>QoLProstateMQ</acronym>
  <official_title>Quality of Life in Prostate Cancer Patients: Challenges and Prospects for Reducing Disparities in the Caribbean</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Center of Martinique</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Regional Development Fund</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Center of Martinique</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recording cancer data in cancer registries is essential for producing reliable
      population-based data for service planning, monitoring and evaluation. Prostate cancer (PCa)
      remains the most frequent type of cancer in terms of incidence and mortality in men in the
      Caribbean. The quality of life PCa cohort will assess quality of life and patient outcomes in
      Martinique using a digital platform for patient-reported outcome measures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Martinique Cancer Registry database is the largest clinical database among the French
      population-based cancer registries in the Caribbean, including more than 38 000 cancer cases,
      with 1650 new cancer cases per year, including 550 new PCa cases per year (2010-2014 latest
      period). In 2020, follow-up will include vital status, assessment of quality of life with the
      European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire
      (QLQ) Core 30 and the Prostate cancer module QLQ-PR25. Urinary incontinence and erectile
      dysfunction recorded prior to treatment will be analysed 1, 3 and 5 years after treatment.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 6, 2020</start_date>
  <completion_date type="Anticipated">June 1, 2026</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of overall Quality of Life: Questionnaire</measure>
    <time_frame>At the date of diagnosis of the disease, at 1 year, 3 years and 5 years</time_frame>
    <description>Change of quality of life questionnaire related to sexual dysfunction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of overall Quality of Life: Questionnaire</measure>
    <time_frame>At the date of diagnosis of the disease, at 1 year, 3 years and 5 years</time_frame>
    <description>Change of quality of life questionnaire related to urinary troubles</description>
  </primary_outcome>
  <enrollment type="Anticipated">304</enrollment>
  <condition>Prostate Cancer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with prostate cancer diagnosed in Martinique in differents units care.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age&gt;18 years and residing in Martinique, with prostate cancer diagnosed from 2020

          -  The patient has provided informed consent

          -  Patient with social security coverage

        Exclusion Criteria:

          -  Refusal to participate

          -  Patient with a second cancer, five years after diagnosis

          -  Patient who could not answer the quality of life questionnaires

          -  Patient not fluent in French

          -  Person under legal protection
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clarisse CONTARET-JOACHIM</last_name>
    <role>Study Director</role>
    <affiliation>CHU Martinique</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Clarisse CONTARET-JOACHIM</last_name>
    <phone>+596 596 55 96 74</phone>
    <email>Clarisse.JOACHIM@chu-martinique.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mickaelle ROSE</last_name>
    <phone>+596 596 59 26 23</phone>
    <email>mickaelle.rose@chu-martinique.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de Martinique</name>
      <address>
        <city>Fort de France</city>
        <country>Martinique</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincent VINH-HUNG, MD</last_name>
      <phone>+596 596 59 25 03</phone>
      <email>anhxang@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Martinique</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>April 17, 2020</study_first_submitted>
  <study_first_submitted_qc>April 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 22, 2020</study_first_posted>
  <last_update_submitted>July 15, 2020</last_update_submitted>
  <last_update_submitted_qc>July 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Prostate</keyword>
  <keyword>Public Health</keyword>
  <keyword>Quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

